When is Subnational, Supralocal Tobacco Control "just right"? A Qualitative Study in England.


Journal

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751

Informations de publication

Date de publication:
13 07 2022
Historique:
received: 30 11 2021
revised: 04 03 2022
accepted: 11 03 2022
pubmed: 15 3 2022
medline: 16 7 2022
entrez: 14 3 2022
Statut: ppublish

Résumé

Subnational, supralocal (or "regional") approaches to tobacco control are often central federal nation tobacco control and can be superfluous for very small nations. However, their relevance to countries with weak intermediate tiers of governance are less clear. This study explores expert and policymaker perceptions on the function, form, footprint, and funding of regional tobacco control (RTC) in England. One-to-one semistructured interviews (n = 16) and four focus groups (n = 26) exploring knowledge and perceptions of the past, present, and future of RTC in England were conducted with public health leaders, clinicians, tobacco control practitioners, civil servants, and politicians. Interviews were audio-recorded, transcribed verbatim, and analyzed thematically. Participants reported several key functions for RTC, including illicit tobacco control, media campaigns, advocacy, policy development, and network facilitation for local actors. A small minority of participants reported little role for RTC. Broader perceived features of effective RTC included subject expertise, strong regional ties, systems leadership, and a distinctive program of work. Views varied on whether regional programs should be developed nationally or locally, and their optimal footprint. Participants generally agreed stable funding was a prerequisite for success, although there was lesser agreement on funding sources. Pooling resources at the regional level in countries with weak intermediate tiers of governance may increase reach, cost-effectiveness and impact of campaigns, policy interventions, and advocacy, whilst retaining the ability to tailor approaches to regional populations. There are likely to be greater funding and governance challenges associated with introducing or strengthening RTC in countries with weak intermediate tiers of governance. Despite this, evidence from England shows it is possible to develop RTC approaches reported as effective by key stakeholders. Possible benefits of regional approaches in this context include cost-effective delivery of illicit tobacco control, media campaigns, advocacy, research, policy development, and coordinated support for local action on tobacco.

Identifiants

pubmed: 35287176
pii: 6548390
doi: 10.1093/ntr/ntac069
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1241-1246

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Nathan Philip Davies (NP)

University of Nottingham, School of Medicine, Nottingham, UK.
Action on Smoking and Health, London, UK.

Hazel Cheeseman (H)

Action on Smoking and Health, London, UK.

Deborah Arnott (D)

Action on Smoking and Health, London, UK.

Elizabeth Pierce (E)

Action on Smoking and Health, London, UK.
East Midlands School of Public Health, Leicester, UK.

Tessa Elizabeth Langley (TE)

University of Nottingham, School of Medicine, Nottingham, UK.
SPECTRUM Consortium, Edinburgh, UK.

Rachael Murray (R)

University of Nottingham, School of Medicine, Nottingham, UK.
SPECTRUM Consortium, Edinburgh, UK.

Ilze Bogdanovica (I)

University of Nottingham, School of Medicine, Nottingham, UK.
SPECTRUM Consortium, Edinburgh, UK.

Manpreet Bains (M)

University of Nottingham, School of Medicine, Nottingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH